A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Clinical trial NCT06328608 · RECRUITING
Trial details
- NCT number
- NCT06328608
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-29
- Primary completion
- 2028-10-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.